S. Wei

发表

Receptor Activator of Nuclear Factor- B Ligand Activates Nuclear Factor- B in Osteoclast Precursors

S. Wei, 2001 .

Receptor Activator of Nuclear Factor-κB Ligand Activates Nuclear Factor-κB in Osteoclast Precursors.

Shi Wei, S. Teitelbaum, F. Ross, 2001, Endocrinology.

The HIV protease inhibitor ritonavir blocks osteoclastogenesis and function by impairing RANKL-induced signaling.

Michael W.-H. Wang, Shi Wei, R. Faccio, 2004, The Journal of clinical investigation.

Interleukin-4 Reversibly Inhibits Osteoclastogenesis via Inhibition of NF-κB and Mitogen-activated Protein Kinase Signaling*

Shi Wei, S. Teitelbaum, F. Ross, 2002, The Journal of Biological Chemistry.

Molecular mechanisms of the biphasic effects of interferon-γ on osteoclastogenesis.

Jing Cheng, Shi Wei, Zhenqi Shi, 2012, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Tumor Necrosis Factor α Regulatesα vβ5 Integrin Expression by Osteoclast Precursors in Vitro and in Vivo1.

Shi Wei, S. Teitelbaum, F. Ross, 2000, Endocrinology.

STAT3 activation is a critical step in gp130-mediated terminal differentiation and growth arrest of a myeloid cell line.

S. Akira, K. Takeda, Shi Wei, 1996, Proceedings of the National Academy of Sciences of the United States of America.

IL-1 mediates TNF-induced osteoclastogenesis.

Shi Wei, S. Teitelbaum, F. Ross, 2005, The Journal of clinical investigation.

Receptor Activator of NF-κB (RANK) Cytoplasmic Motif, 369PFQEP373, Plays a Predominant Role in Osteoclast Survival in Part by Activating Akt/PKB and Its Downstream Effector AFX/FOXO4*

Shi Wei, Li Sun, Xu Feng, 2005, Journal of Biological Chemistry.

Receptor Activator of Nuclear Factor-κB Ligand Activates Nuclear Factor-κB in Osteoclast Precursors.

Michael W.-H. Wang, Shi Wei, S. Teitelbaum, 2001, Endocrinology.

Receptor Activator of Nuclear Factor-kB Ligand Activates Nuclear Factor-kB in Osteoclast Precursors*

S. Teitelbaum, S. Wei, F. P. Ross, 2001 .

Marrow Stromal Cells and Osteoclast Precursors Differentially Contribute to TNF-α-Induced Osteoclastogenesis In Vivo1

Matthew J. Silva, Shi Wei, S. Takeshita, 2004, The Journal of Immunology.

Receptor Activator of Nuclear Factor- B Ligand Activates Nuclear Factor- B in Osteoclast Precursors

Shi Wei, S. Teitelbaum, F. Ross, 2001 .

Lactoferrin inhibits apoptosis through insulin-like growth factor I in primary rat osteoblasts

Shi Wei, Ying Xue, Jianming Hou, 2014, Acta Pharmacologica Sinica.

Tumor Necrosis Factor a Regulates a v b 5 Integrin Expression by Osteoclast Precursors in Vitro and in Vivo*

Shi Wei, S. Teitelbaum, F. Ross, 1999 .

Molecular Basis of Requirement of Receptor Activator of Nuclear Factor κB Signaling for Interleukin 1-mediated Osteoclastogenesis*

Shi Wei, S. Michalek, Zhenqi Shi, 2012, The Journal of Biological Chemistry.

The alternative pathaway of human T cell activation by monoclonal antibodies

C. Feng, Liu Yanfen, Huang Yirong, 1990 .

The IVVY Motif and Tumor Necrosis Factor Receptor-associated Factor (TRAF) Sites in the Cytoplasmic Domain of the Receptor Activator of Nuclear Factor κB (RANK) Cooperate to Induce Osteoclastogenesis*

Shi Wei, Zhenqi Shi, Xu Feng, 2015, The Journal of Biological Chemistry.

Interleukin‐4 inhibits RANKL‐induced NFATc1 expression via STAT6: A novel mechanism mediating its blockade of osteoclastogenesis

Jing Cheng, G. Siegal, Zhenqi Shi, 2011, Journal of cellular biochemistry.

Induced Osteoclastogenesis In Vivo α Precursors Differentially Contribute to TNF-Marrow Stromal Cells and Osteoclast

Matthew J. Silva, Shi Wei, S. Takeshita, 2004 .